Marc Feldmann

Marc Feldmann
Sir Marc Feldmann
Born 2 December 1944 (1944-12-02) (age 66)
France
Residence London, England
Citizenship Australian/U.K.
Fields Immunology
Institutions Kennedy Institute of Rheumatology, Imperial College School of Medicine
Alma mater University of Melbourne
Walter and Eliza Hall Institute of Medical Research
Known for discovery of anti-TNF therapy as an effective treatment for rheumatoid arthritis and other autoimmune diseases
Notable awards Crafoord Prize (2000)
Albert Lasker Award for Clinical Medical Research (2003)
EPO European Inventor of the Year Award (2007)
Dr. Paul Janssen Award for Biomedical Research (2008)

Sir Marc Feldmann (born 2 December 1944) is an Australian immunologist, and a professor at the Imperial College School of Medicine where he is a head of the Kennedy Institute of Rheumatology.

Contents

Biography

Feldman was born 2 December 1944 in Lvov, Poland near the Russian border to a Jewish family who managed to get to France immediately postwar.[1][2] He emigrated from France to Australia at age eight.[2] After graduating with an MBBS degree from the University of Melbourne in 1967, he earned a Ph.D. in Immunology at the Walter and Eliza Hall Institute of Medical Research in 1972 with Sir Gustav Nossal.[1]

He moved to London in the 1970s, working first with Professor Avrion Mitchison at the Imperial Cancer Research Fund's Tumour Immunology Unit, then in 1985 moved to the Charing Cross Sunley Research Centre and the Kennedy Institute of Rheumatology which joined with the Faculty of Medicine at Imperial College in 2000.[1]

In the 1980s he published a new hypothesis for the mechanism of induction of autoimmune diseases, highlighting the role of cytokines. Cytokines are potent signalling proteins, local hormones, which drive important processes like inflammation, immunity and cell growth. This model was validated in experiments with thyroid disease tissue. From 1984 he collaborated with Ravinder N. Maini at the Kennedy Institute of Rheumatology to study disease mechanism in rheumatoid arthritis, a much more clinically important autoimmune disease, affecting 1% of the population.[3]

In autoimmune diseases, the immune system attacks and damages the body, leading to diease of various organs, for example joints in rheumatoid arthritis. Feldmann's group demonstrated that diseased joints have far more pro-inflammatory cytokines than normal, and identified one of these, Tumour Necrosis Factor Alpha, abbreviated TNFα as the key.

Blocking TNFα reduced levels of the other pro-inflammatory cytokines in test-tube models of arthritis, and this provided the rationale for testing TNF blockade in rheumatoid arthritis patients which had failed all existing treatment.

The first of a series of successful clinical trials was performed in 1992, at Charing Cross Hospital, now part of Imperial College Health Care Trusts Academic Health Science Centre, using an antibody, infliximab from Centocor, a biotech now part of Johnson and Johnson.

The success led to other companies joining the race to market, and by 1998, etanercept (Enbrel) was approved for treatment in the US, and by 1999, infliximab (Remicade) was also approved. Now there are 5 approved antiTNF drugs, and they are extensively used, with more than 2 million successfully treated patients.

Since then, TNFα inhibitors have become the therapy of choice for stopping the inflammatory and tissue-destructive pathways of rheumatoid arthritis and other autoimmune diseases including Crohn's disease, ulcerative colitis, ankylosing spondylitis, psoriasis and psoriatic arthritis.[3]

Prizes and fellowships

Marc Feldmann and Ravinder Maini shared many awards for their discovery. In 2000, Feldmann and Maini were awarded the Crafoord Prize "for identification of TNF blockade as an effective therapeutic principle in rheumatoid arthritis".[4][5] In 2003, the two were awarded the Albert Lasker Award for Clinical Medical Research for discovery of anti-TNF therapy as an effective treatment for rheumatoid arthritis and other autoimmune diseases.[6] In 2004, the Cameron Prize for Therapeutics of University of Edinburgh. In 2007, Feldmann was awarded The European Patent Offices "European Inventor of the Year" in the Lifetime Achievement Category.[3] In 2008 he was awarded the Dr. Paul Janssen Award for Biomedical Research together with Maini.[7] He was awarded the John Curtin Medal of the Australian National University.

He is Fellow of the Royal College of Physicians and of the Royal College of Pathologists. He was elected a Fellow of several national Academies, the Academy of Medical Sciences, the Royal Society of London and is a Corresponding Member of Australian Academy of Science,[8] and a Foreign Member of the National Academy of Sciences, USA. He was knighted in the 2010 Queen's Birthday Honours.[9]

References

  1. ^ a b c "Feldmann, Marc". ISIHighlyCited.com. http://hcr3.isiknowledge.com/author.cgi?&link1=Results&id=399. Retrieved 21 November 2008. 
  2. ^ a b "Marc Feldmann". Johnson & Johnson Pharmaceutical Services. http://www.pauljanssenaward.com/winners/Marc_Feldmann_Bio.pdf#zoom=100. Retrieved 21 November 2008. 
  3. ^ a b c "Professor Marc Feldmann wins top lifetime achievement award". News-Medical.Net. http://www.news-medical.net/?id=24113. Retrieved 21 November 2008. 
  4. ^ "Crafoord Prize 2000". The Royal Swedish Academy of Sciences. http://www.kva.se/KVA_Root/eng/awards/search_laureates/detail.asp?LaureateID=405&PrizeYear=2000&PrizeID=4&LanguageID=2&SubjectID=8. Retrieved 23 November 2008. [dead link]
  5. ^ "Crafoord Prize 2000 Press Release". The Royal Swedish Academy of Sciences. http://www.kva.se/KVA_Root/eng/_press/detail_print.asp?NewsId=325. Retrieved 24 November 2008. [dead link]
  6. ^ "The 2003 Albert Lasker Clinical Medical Research Award". Lasker Foundation. http://www.laskerfoundation.org/awards/2003_c_description.htm. Retrieved 21 November 2008. 
  7. ^ "Professors Marc Feldmann and Sir Ravinder Maini Named Winners of the 2008 Dr. Paul Janssen Award for Biomedical Research". Johnson & Johnson Pharmaceutical Services. http://www.pauljanssenaward.com/2008_award_annoucement.html. Retrieved 23 November 2008. 
  8. ^ "Professional Activities". Imperial College London. http://www1.imperial.ac.uk/medicine/people/m.feldmann/activities/. Retrieved 23 November 2008. 
  9. ^ London Gazette: (Supplement) no. 59446. p. 1. 12 June 2010.

External links


Wikimedia Foundation. 2010.

Игры ⚽ Нужно сделать НИР?

Look at other dictionaries:

  • Marc Feldmann — Marc Feldmann, doctor en medicina e inmunólogo británico, líder del equipo de investigación del Kennedy Institute of Rheumatology de Londres, centro desde el cual buscan nuevos fármacos y tratamientos para la artritis reumatoidea, como las… …   Wikipedia Español

  • Marc Feldmann — Doctor en medicina inmunológica británico, líder del equipo de investigación del Kennedy Institute of Rheumatology de Londres, centro desde el cual buscan nuevos fármacos y tratamientos para la artritis reumatoidea, como las sustancias anti TNF,… …   Enciclopedia Universal

  • Marc-Emile Ruchet — (September 14, 1853 July 13, 1912) was a Swiss politician. He was elected to the Swiss Federal Council on December 14, 1899, and resigned on July 9, 1912, only four days before his death. He was affiliated with the Free Democratic Party. While in …   Wikipedia

  • Imperial College School of Medicine — Established 1821 Charing Cross Hospital Medical School 1834 Westminster Hospital Medical School 1854 St Mary s Hospital Medical School 1984 Charing Cr …   Wikipedia

  • Paul Janssen — Statue of Dr. Paul Janssen in Beerse, Belgium Paul Adriaan Jan, Baron Janssen (born on 12 September 1926 in Turnhout, Belgium – 11 November 2003 in Rome, Italy) was the founder of Janssen Pharmaceutica, a pharmaceutical company with over 20,000… …   Wikipedia

  • Ravinder N. Maini — Sir Ravinder Maini (1937 ) is rheumatology professor at the Kennedy Institute, part of Imperial College London. Maini was born in Ludhiana in the Punjab region of India but has lived most of his life in the UK. He did his bachelor s degree at… …   Wikipedia

  • European Inventor of the Year — The European Inventor of the Year awards are presented annually by the European Patent Office and the European Commission s DG Enterprise and Industry to inventors who have made a significant contribution to innovation in Europe. The winners in… …   Wikipedia

  • Calendar of 2003 — ▪ 2004 January So long as there is a single Brazilian brother or sister going hungry, we have ample reason to be ashamed of ourselves. Lula, in his inaugural address as president of Brazil, January 1 January 1       The Socialist Lula (Luiz… …   Universalium

  • Crafoord Prize — The Crafoord Prize Awarded for in astronomy and mathematics, biosciences, geosciences or polyarthritis research, awarded by the Royal Swedish Academy of Sciences Presented by Royal Swedish Academy of Sciences Country Sweden First awarded 1982 …   Wikipedia

  • Lasker Award — The Albert Lasker Medical Research Awards have been awarded annually since 1946 to living persons who have made major contributions to medical science. They are administered by the Lasker Foundation, founded by advertising pioneer Albert Lasker… …   Wikipedia

Share the article and excerpts

Direct link
Do a right-click on the link above
and select “Copy Link”